Bimatoprost is a highly effective IOP lowering drug developed by American Allergan Company. It is unique in pharmacology. It is a synthetic prostaglandin amide, which has strong IOP lowering effect. Bimaprostaglandin may act on FP type prostaglandin receptors through hydrolysis to free acid, so the concentration of bimaprostaglandin is 0.03%.